Absence of myocardial protection with prostacyclin during cardiac arrest

Prostacyclin (PGI 2) has been shown to present myocardial protective effects which could be beneficial during cardiac arrest. We tested this hypothesis in a closed-chest dog model in which electromechanical dissociation (EMD) can be predictably observed after 90 to 120 seconds of ventricular fibrill...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Prostaglandins leukotrienes and medicine 1986-09, Vol.24 (1), p.87-92
Hauptverfasser:	Vincent, Jean-Louis, Domb, Marc, Goldstein, Jacques, Lignian, Herve, Van Belle, Johan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Dogs Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care Epoprostenol - pharmacology Epoprostenol - therapeutic use Heart Arrest - drug therapy Hemodynamics - drug effects Intensive care medicine Medical sciences Resuscitation - methods Ventricular Fibrillation - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!